GridAI Technologies Corp. (GRDX) vs Seres Therapeutics, Inc. (MCRB)

A side-by-side comparison of GridAI Technologies Corp. and Seres Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GRDX vs MCRB

growth of $100 · dividends reinvested · last 10y
GRDX -100.0% (-69.9%/yr)MCRB -98.8% (-35.6%/yr)MCRB compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $10020182020202220242026$0$1
GRDX MCRB

GRDX vs MCRB: by the numbers

  • •GRDX is the larger company ($30M vs $28M market cap).
  • •Both run net losses; MCRB's is the smaller (-1192.94% vs -12789.65% net margin).

Metrics side by side

Valuation

MetricGRDXMCRB
P/S ratio185.4714.91
P/B ratio2.060.81

Profitability

MetricGRDXMCRB
Gross margin-3398.93%-423.83%
Operating margin-19539.98%-11910.14%
Net margin-12789.65%-1192.94%
ROE-111.81%-65.05%
ROIC-42.23%-103.04%

Growth (annualized)

MetricGRDXMCRB
Revenue CAGR (5Y)N/A-42.51%
Total return CAGR (5Y)-83.84%-53.37%

Frequently asked

How have GRDX and MCRB total returns compared?
Over the past 5 years, GRDX delivered -83.84% and MCRB delivered -53.37% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.